Oxygen matters: hypoxia as a pathogenic mechanism in rhinosinusitis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The airway epithelium is the first place, where a defense mechanism is initiated against environmental stimuli. Mucociliary transport (MCT), which is the defense mechanism of the airway and the role of airway epithelium as mechanical barriers are essential in innate immunity. To maintain normal physiologic function, normal oxygenation is critical for the production of energy for optimal cellular functions. Several pathologic conditions are associated with a decrease in oxygen tension in airway epithelium and chronic sinusitis is one of the airway diseases, which is associated with the hypoxic condition, a potent inflammatory stimulant. We have observed the overexpression of the hypoxia-inducible factor 1 (HIF-1), an essential factor for oxygen homeostasis, in the epithelium of sinus mucosa in sinusitis patients. In a series of previous reports, we have found hypoxia-induced mucus hyperproduction, especially by MUC5AC hyperproduction, disruption of epithelial barrier function by the production of VEGF, and down-regulation of junctional proteins such as ZO-1 and E-cadherin. Furthermore, hypoxia-induced inflammation by HMGB1 translocation into the cytoplasm results in the release of IL-8 through a ROS-dependent mechanism in upper airway epithelium. In this mini-review, we briefly introduce and summarize current progress in the pathogenesis of sinusitis related to hypoxia. The investigation of hypoxia-related pathophysiology in airway epithelium will suggest new insights on airway inflammatory diseases, such as rhinosinusitis for clinical application and drug development.
Abstract
The airway epithelium is the first place, where a defense mechanism is initiated against environmental stimuli. Mucociliary transport (MCT), which is the defense mechanism of the airway and the role of airway epithelium as mechanical barriers are essential in innate immunity. To maintain normal physiologic function, normal oxygenation is critical for the production of energy for optimal cellular functions. Several pathologic conditions are associated with a decrease in oxygen tension in airway epithelium and chronic sinusitis is one of the airway diseases, which is associated with the hypoxic condition, a potent inflammatory stimulant. We have observed the overexpression of the hypoxia-inducible factor 1 (HIF-1), an essential factor for oxygen homeostasis, in the epithelium of sinus mucosa in sinusitis patients. In a series of previous reports, we have found hypoxia-induced mucus hyperproduction, especially by MUC5AC hyperproduction, disruption of epithelial barrier function by the production of VEGF, and down-regulation of junctional proteins such as ZO-1 and E-cadherin. Furthermore, hypoxia-induced inflammation by HMGB1 translocation into the cytoplasm results in the release of IL-8 through a ROS-dependent mechanism in upper airway epithelium. In this mini-review, we briefly introduce and summarize current progress in the pathogenesis of sinusitis related to hypoxia. The investigation of hypoxia-related pathophysiology in airway epithelium will suggest new insights on airway inflammatory diseases, such as rhinosinusitis for clinical application and drug development.
참고문헌 (60)
- Zabner J, "Histamine alters E-cadherin cell adhesion to increase human airway epithelial permeability", J Appl Physiol, 95, pp.394~401 (2003)[DOI]
- Jain M, "Effects of hypoxia on the alveolar epithelium", Proc Am Thorac Soc, 2, pp.202~205 (2005)[DOI]
- Bunn HF, "Oxygen sensing and molecular adaptation to hypoxia", Physiol Rev, 76, pp.839~885 (1996)[DOI]
- Steinke JW, "Role of hypoxia in inflammatory upper airway disease", Curr Opin Allergy Clin Immunol, 8, pp.16~20 (2008)[DOI]
- Lok CN, "Identification of a hypoxia response element in the transferrin receptor gene", J Biol Chem, 274, pp.24147~24152 (1999)[DOI]
- Matsune S, "Hypoxia in paranasal sinuses of patients with chronic sinusitis with or without the complication of nasal allergy", Acta Otolaryngol, 123, pp.519~523 (2003)[DOI]
- Rose MC, "Respiratory tract mucin genes and mucin glycoproteins in health and disease", Physiol Rev, 86, pp.245~278 (2006)[DOI]
- Semenza GL, "A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation", Mol Cell Biol, 12, pp.5447~5454 (1992)[DOI]
- Levy AP, "Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia", J Biol Chem, 270, pp.13333~13340 (1995)[DOI]
- Lee PJ, "Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia", J Biol Chem, 272, pp.5375~5381 (1997)[DOI]
- Rolfs A, "Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1", J Biol Chem, 272, pp.20055~20062 (1997)[DOI]
- Wang GL, "Purification and characterization of hypoxia-inducible factor 1", J Biol Chem, 270, pp.1230~1237 (1995)[DOI]
- Neruntarat C, "Uvulopalatal flap for snoring on an outpatient basis", Otolaryngol Head Neck Surg, 129, pp.353~359 (2003)[DOI]
- Semenza GL, "Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis", J Lab Clin Med, 131, pp.207~214 (1998)[DOI]
- Semenza GL, "Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1", J Biol Chem, 271, pp.32529~32537 (1996)[DOI]
- Forsythe JA, "Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1", Mol Cell Biol, 16, pp.4604~4613 (1996)[DOI]
- Li D, "Cloning of the amino-terminal and 5'-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts", J Biol Chem, 273, pp.6812~6820 (1998)[DOI]
- Young HW, "Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5' elements", Am J Respir Cell Mol Biol, 37, pp.273~290 (2007)[DOI]
- Yoon JH, "Mucociliary differentiation according to time in human nasal epithelial cell culture", Differentiation, 70, pp.77~83 (2002)[DOI]
- Kim YJ, "Hypoxia-Mediated Mechanism of MUC5AC Production in Human Nasal Epithelia and Its Implication in Rhinosinusitis", PLoS One, 9, pp.e98136~ (2014)[DOI]
- Miyamoto N, "PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema", Ophthalmic Res, 40, pp.203~207 (2008)[DOI]
- Ahdieh M, "Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma", Am J Physiol Cell Physiol, 281, pp.C2029~C2038 (2001)[DOI]
- Sajjan U, "Rhinovirus disrupts the barrier function of polarized airway epithelial cells", Am J Respir Crit Care Med, 178, pp.1271~1281 (2008)[DOI]
- Weis SM, "Pathophysiological consequences of VEGF-induced vascular permeability", Nature, 437, pp.497~504 (2005)[DOI]
- Aiello LP, "Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders", N Engl J Med, 331, pp.1480~1487 (1994)[DOI]
- Nagashima M, "Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis", J Rheumatol, 22, pp.1624~1630 (1995)
- Jung HH, "Expression of vascular endothelial growth factor in otitis media", Acta Otolaryngol, 119, pp.801~808 (1999)[DOI]
- Matsune S, "Vascular endothelial growth factor produced in nasal glands of perennial allergic rhinitis", Am J Rhinol, 22, pp.365~370 (2008)[DOI]
- Lee YC, "Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma", J Immunol, 168, pp.3595~3600 (2002)[DOI]
- Sun D, "TNF-alpha and endotoxin increase hypoxia-induced VEGF production by cultured human nasal fibroblasts in synergistic fashion", Auris Nasus Larynx, 32, pp.243~249 (2005)[DOI]
- Divekar RD, "Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations", Clin Exp Allergy, 45, pp.767~778 (2015)[DOI]
- Song HA, "Hypoxia Modulates Epithelial Permeability via Regulation of Vascular Endothelial Growth Factor in Airway Epithelia", Am J Respir Cell Mol Biol, 57, pp.527~535 (2017)[DOI]
- Takano K, "HLA-DR- and CD11c-positive dendritic cells penetrate beyond well-developed epithelial tight junctions in human nasal mucosa of allergic rhinitis", J Histochem Cytochem, 53, pp.611~619 (2005)[DOI]
- Nelson WJ, "Adaptation of core mechanisms to generate cell polarity", Nature, 422, pp.766~774 (2003)[DOI]
- Niessen CM, "Tight junctions", adherens junctions: basic structure and function, 2007, pp.127, 2525~2532
- Capaldo CT, "Depletion of E-cadherin disrupts establishment but not maintenance of cell junctions in Madin-Darby canine kidney epithelial cells", Mol Biol Cell, 18, pp.189~200 (2007)
- Takeuchi K, "Histamine alters gene expression in cultured human nasal epithelial cells", J Allergy Clin Immunol, 107, pp.310~314 (2001)[DOI]
- Jang YJ, "Localization of ZO-1 and E-cadherin in the nasal polyp epithelium", Eur Arch Otorhinolaryngol, 259, pp.465~469 (2002)
- Yeo NK, "Rhinovirus infection-induced alteration of tight junction and adherens junction components in human nasal epithelial cells", Laryngoscope, 120, pp.346~352 (2010)
- 민현진, "Hypoxia Increases Epithelial Permeability in Human Nasal Epithelia", Yonsei Medical Journal, 56(3), pp.825~831 (2015), 연세대학교의과대학[DOI]
- Lotze MT, "High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal", Nat Rev Immunol, 5, pp.331~342 (2005)[DOI]
- Bonaldi T, "Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion", EMBO J, 22, pp.5551~5560 (2003)[DOI]
- Hori O, "The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system", J Biol Chem, 270, pp.25752~25761 (1995)[DOI]
- Tang D, "Endogenous HMGB1 regulates autophagy", J Cell Biol, 190, pp.881~892 (2010)[DOI]
- Han SJ, "HMGB1 in the pathogenesis of ultraviolet-induced ocular surface inflammation", Cell Death Dis, 6, pp.e1863~ (2015)[DOI]
- Min HJ, "Level of secreted HMGB1 correlates with severity of inflammation in chronic rhinosinusitis", Laryngoscope, 125, pp.E225~E230 (2015)[DOI]
- Itoh T, "High-mobility group box 1 expressions in hypoxia-induced damaged mouse islets", Transplant Proc, 43, pp.3156~3160 (2011)[DOI]
- Hamada T, "Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis", Arthritis Rheum, 58, pp.2675~2685 (2008)[DOI]
- Min HJ, "ROS-dependent HMGB1 secretion upregulates IL-8 in upper airway epithelial cells under hypoxic condition", Mucosal Immunol, 10, pp.685~694 (2017)[DOI]
- Desireddi JR, "Hypoxia increases ROS signaling and cytosolic Ca(2+) in pulmonary artery smooth muscle cells of mouse lungs slices", Antioxid Redox Signal, 12, pp.595~602 (2010)[DOI]
- Joo JH, "Dual oxidase 2 is essential for the toll-like receptor 5-mediated inflammatory response in airway mucosa", Antioxid Redox Signal, 16, pp.57~70 (2012)[DOI]
- Riechelmann H, "Biological markers in nasal secretions", Eur Respir J, 21, pp.600~605 (2003)[DOI]
- Riechelmann H, "Nasal biomarker profiles in acute and chronic rhinosinusitis", Clin Exp Allergy, 35, pp.1186~1191 (2005)[DOI]
- Kramer MF, "In vitro diagnosis of chronic nasal inflammation", Clin Exp Allergy, 34, pp.1086~1092 (2004)[DOI]
- Deroee AF, "Nitric oxide metabolites as biomarkers for follow-up after chronic rhinosinusitis surgery", Am J Rhinol Allergy, 23, pp.159~161 (2009)[DOI]
- Shimizu S, "HMGB1-TLR4 signaling contributes to the secretion of interleukin 6 and interleukin 8 by nasal epithelial cells", Am J Rhinol Allergy, 30, pp.167~172 (2016)[DOI]
- Paris G, "Damage-associated molecular patterns stimulate interleukin-33 expression in nasal polyp epithelial cells", Int Forum Allergy Rhinol, 4, pp.15~21 (2014)[DOI]
- Yang H, "The cytokine activity of HMGB1", J Leukoc Biol, 78, pp.1~8 (2005)[DOI]
- Lv B, "High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1", Thromb Haemost, 102, pp.352~359 (2009)[DOI]
- Fiuza C, "Inflammationpromoting activity of HMGB1 on human microvascular endothelial cells", Blood, 101, pp.2652~2660 (2003)[DOI]
